2017
DOI: 10.1016/j.yexmp.2017.02.005
|View full text |Cite
|
Sign up to set email alerts
|

Endothelial cell markers from clinician's perspective

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
51
0
6

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 73 publications
(57 citation statements)
references
References 140 publications
0
51
0
6
Order By: Relevance
“…Finally, CYP46A1 immunolocalization was conducted in retinal flat mounts and cross sections, which were also stained for CD31, a marker of vascular endothelial cells, or neuronal-specific nuclear protein, a DNA-binding protein that identifies many populations of mature neurons. 61,62 In both flat mounts and cross sections, the immunoreactivity for CYP46A1 overlapped in part with that for CD31 ( Figure 10A). There was also CYP46A1 immunoreactivity outside retinal blood vessels, which could reflect CYP46A1 expression in some of the retinal neurons.…”
Section: Gene Expression In Retinal Endothelial Cells and Rpementioning
confidence: 96%
“…Finally, CYP46A1 immunolocalization was conducted in retinal flat mounts and cross sections, which were also stained for CD31, a marker of vascular endothelial cells, or neuronal-specific nuclear protein, a DNA-binding protein that identifies many populations of mature neurons. 61,62 In both flat mounts and cross sections, the immunoreactivity for CYP46A1 overlapped in part with that for CD31 ( Figure 10A). There was also CYP46A1 immunoreactivity outside retinal blood vessels, which could reflect CYP46A1 expression in some of the retinal neurons.…”
Section: Gene Expression In Retinal Endothelial Cells and Rpementioning
confidence: 96%
“…These studies speculated the potential prognostic inferiority of pan-endothelial markers (i.e vWF, CD31, CD34) was caused by the additional staining of pre-existing angiogenically inactive vessels [23]. In contrast, many studies have shown that CD105 predominantly stain proliferating endothelial cells [22, 33, 38–46]. However, a few studies have observed CD105-positive vessels in normal [47] and GBM-adjacent brain tissue [48], and the marker needs further validation.…”
Section: Discussionmentioning
confidence: 99%
“…The MVDs were immunohistochemically assessed by means of two endothelial markers: von Willebrand factor (vWF or FVIII related antigen), a pan-endothelial marker [22], which illustrates the metabolic demand of the tumor [23]; and endoglin (CD105), a marker of proliferating endothelial cells [24], which reflects the degree of angiogenesis [23]. In addition, we investigated the correlation between the MVDs and their associations with the histopathological features thromboses, high cellular density, high vascular density, and mitotic count.…”
Section: Introductionmentioning
confidence: 99%
“…VEGF играет важнейшую роль в таких процессах, как деградация базальной мембраны ЭК и внеклеточного матрикса, пролиферация ЭК, формирование капилляров, синтез новой базальной мембраны. Таким образом, VEGF оказывается вовлечен во все этапы ангиогенеза [39,46]. Изоформа VEGF-A существует в виде 4 различных подтипов: VEGF121, VEGF165, VEGF189 и VEGF206 [51] и считается первым ростовым фактором, характерным именно для ЭК, который появляется в ходе эмбрионального развития.…”
Section: Introductionunclassified
“…Именно VEGF-A является ключевой молекулой, индуцирующей васкулогенез и ангиогенез [39]. VEGF-A был открыт как фактор проницаемости сосудов, затем была показана его роль в пролиферации, миграции, про растании сосудов и формировании трубок сосудов [13,39]. Сильнейшим стимулом, вызывающим секрецию VEGF, является гипоксия.…”
Section: Introductionunclassified